Ophthalmology / Age-Related Macular Degeneration
Indication
Age-Related Macular Degeneration
Assets addressing this indication.
Total attributable cost
$486.2B
$24,520/patient
Drug spend
$9.7B
$490/patient
2% of total cost is drugs
All stages and forms (US estimate) · US